Tarsus Pharmaceuticals, Inc. Common Stock
$75.69
▼ 0.27
(-0.35%)
Volume: 561,487
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
57
- 21d momentum +7.1%
- RSI 49
🎯
Pullback
50
- -4.2% vs 20MA
💎
Value
58
- -17% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)49.4
MACD-1
MA trendMixed
ATR4.09%
21d mom.+7.1%
63d mom.+20.3%
vs 20MA-4.2%
RVOL(20)0.71×
52w low · 54
52w high · 92
-17.3% from 52-week high
20d support 71
· resistance 92
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$3.6B
PER—
PBR10.25
PSR5.86
EPS$-1.00
ROE-13.5%
ROA-7.7%
Dividend yield0.00%
Debt/Equity0.21
EV/EBITDA-66.23
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -3.07% | +7.13% | +20.30% | +12.63% | +36.97% | -6.29% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -16.62%, daily vol 3.44%. Tarsus Pharmaceuticals, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.